The secondary endpoint of fibrosis reduction by at least one stage was documented in 34%, 36%, and 34% of participants receiving survodutide compared to 22% of placebo, demonstrating potential anti-fibrotic benefit [23]
However, current data from SEMA clinical trials indicate that therapeutic effects on liver fibrosis are unclear, with potential benefits possibly involving the delay of fibrosis progression
Remember, medications like phentermine and Wegovy/Ozempic are only one part of the plan to achieve your overall health goals
In these cases, the liver may not be able to properly metabolize vitamin B12, leading to a build-up of the vitamin in the body
If your protocol specifies a per-component dose, divide by the labelled ratio (often 1:1) before entering the target
Fiber comes in two forms, both of which are vital for health: soluble and insoluble